COSCIENS Biopharma Inc. Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill
COSCIENS Biopharma Inc. (CSCIF) reported Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill of $7.64 million for the 12-month period ending 2022-12-31, per its 20-F/A filed 2024-07-17.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForImpairmentLossRecognisedInProfitOrLossGoodwill · last filed 2024-07-17
| Period end | Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill 12 month |
|---|---|
| 2022-12-31 | $7.64M 20-F/A · filed 2024-07-17 |